首页> 美国卫生研究院文献>Indian Journal of Clinical Biochemistry >Modulation of Angiogenesis Proliferative Response and Apoptosis by β-Sitosterol in Rat Model of Renal Carcinogenesis
【2h】

Modulation of Angiogenesis Proliferative Response and Apoptosis by β-Sitosterol in Rat Model of Renal Carcinogenesis

机译:β-谷甾醇在大鼠肾癌模型中对血管生成增殖反应和凋亡的调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As expanded understanding of molecular tumor characteristics, which drive renal cancer growth and progression gives a promising future for renal carcinoma therapy. The objective of the present study was designed to examine the effect of β-sitosterol on a rat model of experimental renal carcinogenesis. Renal carcinogenesis was induced in rats treated with N-diethylnitrosamine (DEN; 200 mg/kg bw single i.p., injection) and ferric nitrilotriacetate (Fe-NTA; 9 mg Fe/kg bw i.p., twice a week for 16 weeks). β-sitosterol pretreatment (20 mg/kg bw in 0.1 % carboxymethyl cellulose (CMC) p.o., thrice a week for 24 weeks) was started 2 weeks before the exposure to carcinogens. Expression of angiogenesis marker (VEGF), proliferative markers (cyclin D1, PCNA) and apoptotic markers (Bcl-2, Bax, caspase-3 and caspase-9) were analyzed to assess the anti-cancer potential of β-sitosterol in renal carcinogenesis model. mRNA and protein expression changes were determined by qRT-PCR, Western blotting, ELISA technique and immunohistochemistry. Our results showed that oral administration of β-sitosterol pretreatment significantly (P < 0.05) reversed the expression of all the above mentioned markers and histological features which have been modified by renal carcinogen. It is concluded that, the protective effects of β-sitosterol against renal cancer is associated with the induction of apoptosis and the inhibition of cellular proliferation.
机译:随着对分子肿瘤特征的深入理解,分子特征驱动肾癌的生长和发展,为肾癌的治疗带来了广阔的前景。本研究的目的旨在检查β-谷甾醇对实验性肾癌发生大鼠模型的影响。用N-二乙基亚硝胺(DEN; 200 mg / kg bw单次腹腔注射,注射)和次氮铁三乙酸铁(Fe-NTA; 9mg Fe / kg bw i.p.,每周两次,连续16周)诱导大鼠肾癌发生。在暴露于致癌物之前2周开始进行β-谷固醇预处理(在0.1%羧甲基纤维素(CMC)中,20 mg / kg体重,每周两次,连续24周)。分析血管生成标记物(VEGF),增殖性标记物(cyclin D1,PCNA)和凋亡标记物(Bcl-2,Bax,caspase-3和caspase-9)的表达,以评估β-谷固醇在肾脏癌变中的抗癌潜力。模型。通过qRT-PCR,Western印迹,ELISA技术和免疫组化测定mRNA和蛋白质表达的变化。我们的结果表明,口服β-谷固醇预处理显着(P <0.05)逆转了上述所有标记的表达和已被肾致癌物修饰的组织学特征。结论是,β-谷甾醇对肾癌的保护作用与细胞凋亡的诱导和细胞增殖的抑制有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号